Skip to main content

RHUMBLINE ADVISERS

Position in ASND — Ascendis Pharma A/S

CIK 1115418 BOSTON, MA

Position in ASND

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$12,965,792
+$12,571,233 QoQ
Shares Held
48,612
+2718.1% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#84
of 307 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 44% Shared 0% None 56%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ASND ranks #24 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ASND

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,965,792 48,612
2026-03-31 $394,559 1,725
2025-12-31 $370,824 1,739
2025-09-30 $225,649 1,135
2025-06-30 $248,716 1,441
2025-03-31 $216,021 1,386
2024-12-31 $200,998 1,460
2024-09-30 $234,118 1,568
2024-06-30 $209,070 1,533
2024-03-31 $210,126 1,390
2023-12-31 $162,475 1,290
2023-09-30 $118,735 1,268
2023-06-30 $112,276 1,258